Efficacy of different doses of sugammadex after continuous infusion of rocuronium

Table 1 Demographic characteristics

Sugammadex (dose)	Group A (n = 16)		Group B (n = 16)		P-value
Age (yr)	43.6	(SD 12.01)	47.1	(SD 14.18)	0.46
Weight (kg)	65.5	(SD 11.22)	60.9	(SD 10.62)	0.25
Height (cm)	163.2	(SD 4.76)	160.1	(SD 5.91)	0.12
BMI (kg/m2)	24.1	(SD 3.56)	23.2	(SD 3.65)	0.47
Intervention (time-minute)	95.2	(SD 26.91)	94.7	(SD 30.02)	0.96
ASA (1-2)	1.4	(SD 0.51)	1.2	(SD 0.48)	0.28
ASA 1a	n = 9	(56.25%)	n = 12	(75.00%)	0.23

Analyzed by student t-test. Both groups are similar.

^aASA 1 is expressed as percentage of patients with an ASA index of 1 in its group and a Fisher exact test was executed. BMI: Body mass index; ASA: American Society of Anesthesiologists.